In this article, we will discuss the 10 Unstoppable Stocks to Buy and Hold for the Next 3 Years.
Fundstrat’s Tom Lee recently appeared on CNBC Television, highlighting that stocks declined mainly because of the software downturn and a general risk-off as gold surged. That being said, he believes earnings have been strong and that economic reports have been good. The positioning has gotten risk-off enough, and there are expectations that the S&P 500 might climb towards 7,300 in a labored way, added Lee.
Federated Hermes Limited, an asset manager, upgraded the forward earnings outlook and raised its 2026 S&P 500 price target from 7,500 to 7,800. As per Stephen Auth, CFA, Executive Vice President, Chief Investment Officer (Equities), productivity gains, revival of economic growth, and expansion of margins continue to fuel the global markets. Considering an anticipated inflation rate of 2.5%, the investment firm opines that nominal US GDP is expected to grow more than 5% in 2026 and 2027.
Companies’ margins are expected to expand because of an ongoing economic mix shift, together with the widening of AI investments.
Amidst such trends, we will now have a look at the 10 Unstoppable Stocks to Buy and Hold for the Next 3 Years.
Our Methodology
To list the 10 Unstoppable Stocks to Buy and Hold for the Next 3 Years, we used a screener to shortlist stocks that have increased 20% over the past year, and analysts still see an upside of at least 20%. Finally, we chose the ones popular among hedge funds, as of Q4 2025. The stocks have been arranged in ascending order of their hedge fund sentiments.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
10 Unstoppable Stocks to Buy and Hold for the Next 3 Years
10. Synchrony Financial (NYSE:SYF)
Synchrony Financial (NYSE:SYF) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 25, the company announced that it renewed its financing partnership with Polaris Inc. For around 2 decades, Synchrony Financial (NYSE:SYF) and Polaris offered Polaris buyers access to customized promotional financing as well as loan options. This is provided through Polaris’ strong US dealer network.
Synchrony Financial (NYSE:SYF) has been enhancing the pace of credit decisions and offering digitalization in a bid to foster financing experiences.
In a separate release, Baird analyst David George upgraded Synchrony Financial (NYSE:SYF)’s stock to “Outperform” from “Neutral” with an unchanged price objective of $83. The analyst opines that, as a result of the share weakness, the risk/reward in the bank seems to be a little better. The stock valuations are more reasonable, and consumer finance has been offering the best risk/reward.
In a different update, Synchrony Financial (NYSE:SYF) announced an expanded strategic partnership with Planet DDS.
We recently covered that Truist lowered Synchrony Financial (SYF) PT to $84, you can read that update here.
9. Baidu, Inc. (NASDAQ:BIDU)
Baidu, Inc. (NASDAQ:BIDU) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 26, the company released its Q4 2025 and FY 2025 results, with total revenues coming at RMB 32.7 billion (or $4.68 billion), reflecting an increase of 5% QoQ, mainly because of an increase in Baidu Core AI-powered Business. Baidu, Inc. (NASDAQ:BIDU)’s revenue from AI Cloud Infra sat at RMB 5.8 billion in Q4 2025, while the subscription-based revenue from AI accelerator infrastructure rose 143% YoY.
The company’s net income came at RMB1.8 billion (or $255 Mn), while its AI Cloud Infra saw strong momentum. Its differentiated full-stack end-to-end AI capabilities earning continued to grow enterprise recognition.
Baidu, Inc. (NASDAQ:BIDU) also highlighted that Apollo Go reinforced global leadership and has been operating at industry-leading scales. Also, it continues to accelerate international expansion in new markets. In Q4 2025, Apollo Go delivered 3.4 million fully driverless operational rides. The weekly rides reached more than 300,000 during the quarter. Notably, total rides went up by more than 200% YoY.
Baidu, Inc. (NASDAQ:BIDU) offers online marketing and non-marketing value-added services. The Baidu Core segment provides feed-based, search-based, and other online marketing services, cloud services, and several other products and services based on AI.
We recently covered that Baidu Inc. (BIDU) boosted its global ride-hailing presence, you can read that update here.
8. QXO, Inc. (NYSE:QXO)
QXO, Inc. (NYSE:QXO) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 25, the company released its financial results for Q4 2025, with QXO, Inc. (NYSE:QXO) reporting a GAAP basic and diluted loss per common share of -$0.17. This mainly reflects acquisition-related amortization and transaction costs. The company continues to execute against its integration plan throughout the legacy Beacon business amidst investments in technology, sales capacity, and other initiatives.
Coming to the M&A, QXO, Inc. (NYSE:QXO)’s agreement to acquire Kodiak Building Partners for $2.25 billion triples its total addressable market to over $200 billion. The company grew its EBITDA run rate to over $1 billion in less than 10 months with Kodiak. While QXO, Inc. (NYSE:QXO)’s acquisition pipeline remains active, it is also on track to achieve annual revenue of $50 billion.
QXO, Inc. (NYSE:QXO)’s net sales came in at $2.19 billion for the 3 months ended December 31, 2025. It expects the acquisition of Kodiak Building Partners to close early in Q2 2026. The acquisition will be highly accretive to the company’s earnings for 2026.
7. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 17, analyst Whitney Ijem from Canaccord Genuity maintained a “Buy” rating on the company’s stock with a price objective of $429.00. The analyst’s rating is supported by the factors related to Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)’s execution and growth outlook.
The analyst noted that the roll-out of AMVUTTRA in transthyretin-mediated amyloidosis continues to outperform initial expectations. The current sales are approximately double of what the broader market expected at the time of approval. Also, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)’s company guidance reflected continued robust expansion of top-line into 2026.
In a different release, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) released its consolidated financial results for Q4 2025 and FY 2025. The company highlighted approval of AMVUTTRA for ATTR-CM in the U.S., fueling its total net product revenues of ~$3 billion, or 81% YoY growth.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is a global biopharmaceutical company and the pioneer of the RNA interference (RNAi) revolution.
6. Insmed Incorporated (NASDAQ:INSM)
Insmed Incorporated (NASDAQ:INSM) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 19, the company released its Q4 2025 and FY 2025 results, with the company highlighting that its US commercial launch of BRINSUPRI has exceeded its expectations. Insmed Incorporated (NASDAQ:INSM) expects FY 2026 BRINSUPRI revenues of at least $1 billion. The company is evaluating the potential effect of evolving US policies, which can impact the timing for future potential international commercial launches.
Insmed Incorporated (NASDAQ:INSM) entered 2026 with momentum, which places the company for leadership across both bronchiectasis and NTM. Over the upcoming year, the company plans to accelerate and expand the US launch of BRINSUPRI. It also plans to grow ARIKAYCE. The company expects FY 2026 ARIKAYCE revenues of between $450 million and $470 million.
It expects that the total of its pre-clinical research programs would make up less than 20% of the overall expenditures.
Insmed Inc. (NASDAQ:INSM) is a biopharmaceutical company that develops and commercializes therapies for patients with serious and rare diseases.
We recently covered that Insmed (INSM) is poised for 2026 upside, you can read that update here.
5. Robinhood Markets, Inc. (NASDAQ:HOOD)
Robinhood Markets, Inc. (NASDAQ:HOOD) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 25, BofA analyst Craig Siegenthaler reduced its price objective on the company’s stock to $122 from $147, while keeping a “Buy” rating, as reported by The Fly. Notably, the firm has been adjusting its EPS estimates for brokers, asset managers, and exchanges that recently reported earnings and are under its coverage.
In a separate release, on February 10, Robinhood Markets, Inc. (NASDAQ:HOOD) released its financial results for Q4 2025 and FY 2025, with quarterly total net revenues rising by 27% YoY to $1.28 billion. Robinhood Markets, Inc. (NASDAQ:HOOD)’s transaction-based revenues rose 15% YoY to $776 million, with net interest revenues rising 39% YoY to $411 million.
Robinhood Markets, Inc. (NASDAQ:HOOD) saw its total platform assets rise by 68% YoY to $324 billion, owing to continued net deposits, acquired assets, and increased equity valuations.
Robinhood Markets, Inc. (NASDAQ:HOOD) operates a financial services platform. The company’s platform enables users to invest in exchange-traded funds (ETFs), options, cryptocurrencies, American Depository Receipts (ADRs), stocks, and gold. It also operates and owns a digital currency marketplace.
4. Carvana Co. (NYSE:CVNA)
Carvana Co. (NYSE:CVNA) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 22, analyst Marvin Fong from BTIG maintained a “Buy” rating on the company’s stock with the price objective of $455.00. This is backed by the company’s updated financial outlook as well as valuation framework.
The analyst marginally raised 2026 revenue forecasts. This comes after he adjusted ADESA Clear sales transitioning to the wholesale segment. Therefore, Fong now expects increased wholesale unit volumes together with a corresponding increase in adjusted EBITDA for Q1 2026 and FY 2026.
While the revisions are incremental, they also reinforce the analyst’s stance that Carvana Co. (NYSE:CVNA)’s earnings power has been improving, thereby supporting a premium multiple on future profitability. The analyst’s price objective was derived by applying a 29x multiple to the 2027 adjusted EBITDA estimate.
In a separate release, Carvana Co. (NYSE:CVNA) released financial results for Q4 2025 and FY 2025, with the company selling 596,641 retail units, reflecting a rise of 43% YoY to reach a record total annual revenue of $20.322 billion, up 49% YoY.
Carvana Co. (NYSE:CVNA) operates an e-commerce platform for buying and selling used cars.
We recently covered that UBS reduced its target price on Carvana (CVNA) stock, you can read that update here.
3. Advanced Micro Devices, Inc. (NASDAQ:AMD)
Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 24, Mizuho analyst Vijay Rakesh lifted its price objective on the company’s stock to $280 from $275, while keeping an “Outperform” rating.
The analyst noted Advanced Micro Devices, Inc. (NASDAQ:AMD)’s expanded partnership with Meta, which focuses on ramping Instinct deployments. While the firm expects 600 bps of gross margin dilution as a result of warrants, it highlighted that Advanced Micro Devices, Inc. (NASDAQ:AMD) believes that the deal is accretive to revenue and earnings.
In a separate release, Advanced Micro Devices, Inc. (NASDAQ:AMD) and Nutanix announced a multi-year strategic partnership. This partnership focuses on jointly developing an open, full-stack AI infrastructure platform. This will help power agentic AI applications.
Advanced Micro Devices, Inc. (NASDAQ:AMD) will invest $150 million in Nutanix common stock. The purchase price will be $36.26 per share. It will finance up to $100 million for Nutanix to help joint engineering initiatives, as well as go-to-market collaboration to ramp up the adoption of AMD and the Nutanix-powered agentic AI platform.
With the help of this partnership, Advanced Micro Devices, Inc. (NASDAQ:AMD) plans to build a scalable, full-stack AI platform, which will be rooted in openness.
Advanced Micro Devices Inc. (NASDAQ:AMD) is a leading semiconductor company specializing in high-performance computing and graphics solutions. Its broad product portfolio includes microprocessors, graphics processors, and system-on-chip (SoC) solutions designed for data centers, gaming, and embedded systems.
2. Broadcom Inc. (NASDAQ:AVGO)
Broadcom Inc. (NASDAQ:AVGO) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 20, analyst William Power from Robert W. Baird maintained a “Buy” rating on the company’s stock with the price objective of $420.00. This rating is backed by a combination of factors, which are associated with Broadcom Inc. (NASDAQ:AVGO)’s AI momentum and earnings potential.
The analyst noted accelerated demand for the company’s v7 custom ASICs powering Google’s TPU infrastructure. This is preferred for AI workloads by well-established customers like OpenAI, Apple, Meta, and Anthropic, and continues to fuel a sharp increase in anticipated AI-related revenue.
As per the analyst, the potential for EPS to exceed $30 by 2030 is backed by the expected AI revenue of ~$65 billion this year, together with a 5-year compound growth outlook of ~45%.
In a different release, on February 19, Broadcom Inc. (NASDAQ:AVGO) launched BroadPeak. This is a radio digital front-end SoC chip, which has been designed to supercharge 5G massive MIMO systems and remote radio heads.
Broadcom Inc. (NASDAQ:AVGO) is a semiconductor and infrastructure software company. It designs and supplies products, including custom chips, networking solutions, and enterprise software used across industries such as cloud computing, telecommunications, and data centers.
1. NVIDIA Corporation (NASDAQ:NVDA)
NVIDIA Corporation (NASDAQ:NVDA) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 Years. On February 26, Wedbush lifted the firm’s price objective on the company’s stock to $300 from $230 while keeping an “Outperform” rating, as reported by The Fly. This comes after the company’s quarterly results, with the firm noting the Q4 2026 acceleration in data center sales. However, it believes that Q1 2027 sales guidance was the main highlight.
In a separate release, RBC Capital lifted its price objective on NVIDIA Corporation (NASDAQ:NVDA)’s stock to $250 from $240, while keeping an “Outperform” rating. The analyst highlighted that NVIDIA Corporation (NASDAQ:NVDA)’s results and outlook beat expectations, with visibility extending into 2027.
Furthermore, the company’s Rubin ramps remain on track, while the gross margins continue to hold up. This is despite elevated memory prices.
For Q1 2027, NVIDIA Corporation (NASDAQ:NVDA) expects revenue of $78.0 billion (plus or minus 2%), with GAAP and non-GAAP gross margins anticipated to be 74.9% and 75.0%, respectively (plus or minus 50 bps).
NVIDIA Corporation (NASDAQ:NVDA) is a fabless semiconductor and AI computing company that designs GPUs, AI accelerators, Application Programming Interfaces (APIs), and system-on-a-chip units. Through its CUDA ecosystem, the company enables industries ranging from autonomous vehicles to scientific research by advancing AI, accelerated computing, and data center infrastructure.
We recently covered that Morgan Stanley maintained a Buy on NVIDIA Corporation (NVDA) stock, you can read that update here.
While we acknowledge the potential of NVDA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVDA and that has 100x upside potential, check out our report about this cheapest AI stock.
READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 High-Flying Stocks to Buy Right Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
